GlassScriptPrepare for your visit
Carol A Nieroda
Emergency Medical Services · Laurel, MD · NPI 1649322785
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,314.75
in general payments reported to CMS, 2019-2025 · $59.20 in 2025
The $59.20 reported for 2025 was less than what a typical Emergency Medical Services provider received nationally (typical 2025 total: $70.35).
Who reported paying
General payments only, top 6 by amount.
- Lilly USA, LLC $299.46
- Boehringer Ingelheim Pharmaceuticals, INC. $211.94
- Novo Nordisk INC $156.10
- Astrazeneca Pharmaceuticals LP $149.45
- Amgen INC. $110.27
- Biotronik INC. $108.84
Drugs and devices associated with these payments
Amyvid Dexcom G6 Transmitter Gemtesa
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Carol Nieroda listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/29521/carol-a-nieroda